List of Tables
Table 1. Global Vasculitis Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Vasculitis Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Vasculitis Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vasculitis Drug Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Vasculitis Drug Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Vasculitis Drug Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Vasculitis Drug Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Vasculitis Drug Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Vasculitis Drug, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Vasculitis Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vasculitis Drug, Product Type & Application
Table 12. Global Key Manufacturers of Vasculitis Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vasculitis Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasculitis Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vasculitis Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vasculitis Drug Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Vasculitis Drug Sales Market Share by Region (2018-2023)
Table 19. Global Vasculitis Drug Sales by Region (2024-2029) & (K Pcs)
Table 20. Global Vasculitis Drug Sales Market Share by Region (2024-2029)
Table 21. Global Vasculitis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Vasculitis Drug Revenue Market Share by Region (2018-2023)
Table 23. Global Vasculitis Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vasculitis Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Vasculitis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vasculitis Drug Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Vasculitis Drug Sales by Country (2024-2029) & (K Pcs)
Table 28. North America Vasculitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Vasculitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vasculitis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vasculitis Drug Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Vasculitis Drug Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe Vasculitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Vasculitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vasculitis Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vasculitis Drug Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Vasculitis Drug Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific Vasculitis Drug Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Vasculitis Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vasculitis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vasculitis Drug Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Vasculitis Drug Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America Vasculitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vasculitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vasculitis Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vasculitis Drug Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Vasculitis Drug Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa Vasculitis Drug Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Vasculitis Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vasculitis Drug Sales (K Pcs) by Type (2018-2023)
Table 51. Global Vasculitis Drug Sales (K Pcs) by Type (2024-2029)
Table 52. Global Vasculitis Drug Sales Market Share by Type (2018-2023)
Table 53. Global Vasculitis Drug Sales Market Share by Type (2024-2029)
Table 54. Global Vasculitis Drug Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Vasculitis Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vasculitis Drug Revenue Market Share by Type (2018-2023)
Table 57. Global Vasculitis Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Vasculitis Drug Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Vasculitis Drug Price (USD/Pcs) by Type (2024-2029)
Table 60. Global Vasculitis Drug Sales (K Pcs) by Application (2018-2023)
Table 61. Global Vasculitis Drug Sales (K Pcs) by Application (2024-2029)
Table 62. Global Vasculitis Drug Sales Market Share by Application (2018-2023)
Table 63. Global Vasculitis Drug Sales Market Share by Application (2024-2029)
Table 64. Global Vasculitis Drug Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Vasculitis Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vasculitis Drug Revenue Market Share by Application (2018-2023)
Table 67. Global Vasculitis Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Vasculitis Drug Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Vasculitis Drug Price (USD/Pcs) by Application (2024-2029)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Merck Vasculitis Drug Product
Table 74. Merck Recent Developments/Updates
Table 75. Bayer Corporation Information
Table 76. Bayer Description and Business Overview
Table 77. Bayer Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. Bayer Vasculitis Drug Product
Table 79. Bayer Recent Developments/Updates
Table 80. Farmalider Corporation Information
Table 81. Farmalider Description and Business Overview
Table 82. Farmalider Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Farmalider Vasculitis Drug Product
Table 84. Farmalider Recent Developments/Updates
Table 85. Hainan Pharmaceutical Factory Corporation Information
Table 86. Hainan Pharmaceutical Factory Description and Business Overview
Table 87. Hainan Pharmaceutical Factory Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Hainan Pharmaceutical Factory Vasculitis Drug Product
Table 89. Hainan Pharmaceutical Factory Recent Developments/Updates
Table 90. Shanghaihuangxiang Lantian Pharmaceutical Corporation Information
Table 91. Shanghaihuangxiang Lantian Pharmaceutical Description and Business Overview
Table 92. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Shanghaihuangxiang Lantian Pharmaceutical Vasculitis Drug Product
Table 94. Shanghaihuangxiang Lantian Pharmaceutical Recent Developments/Updates
Table 95. Huzhou Konch Pharmaceutical Corporation Information
Table 96. Huzhou Konch Pharmaceutical Description and Business Overview
Table 97. Huzhou Konch Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. Huzhou Konch Pharmaceutical Vasculitis Drug Product
Table 99. Huzhou Konch Pharmaceutical Recent Developments/Updates
Table 100. CSPC Ouyi Pharmaceutical Corporation Information
Table 101. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 102. CSPC Ouyi Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. CSPC Ouyi Pharmaceutical Vasculitis Drug Product
Table 104. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 105. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Corporation Information
Table 106. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Description and Business Overview
Table 107. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Vasculitis Drug Product
Table 109. Sino-US Zibo Xinhua-Perrigo Pharmaceutical Recent Developments/Updates
Table 110. Hubei Biocause Pharmaceutical Corporation Information
Table 111. Hubei Biocause Pharmaceutical Description and Business Overview
Table 112. Hubei Biocause Pharmaceutical Vasculitis Drug Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Hubei Biocause Pharmaceutical Vasculitis Drug Product
Table 114. Hubei Biocause Pharmaceutical Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Vasculitis Drug Distributors List
Table 118. Vasculitis Drug Customers List
Table 119. Vasculitis Drug Market Trends
Table 120. Vasculitis Drug Market Drivers
Table 121. Vasculitis Drug Market Challenges
Table 122. Vasculitis Drug Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vasculitis Drug
Figure 2. Global Vasculitis Drug Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Vasculitis Drug Market Share by Type in 2022 & 2029
Figure 4. Blisibimod Product Picture
Figure 5. CCX-168 Product Picture
Figure 6. Gevokizumab Product Picture
Figure 7. Rituximab Biosimilar Product Picture
Figure 8. Others Product Picture
Figure 9. Global Vasculitis Drug Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 10. Global Vasculitis Drug Market Share by Application in 2022 & 2029
Figure 11. Polyarteritis Nodosa
Figure 12. Thrombotic Vasculitis
Figure 13. Granulomatous Vasculitis
Figure 14. Lymphocytic Vasculitis
Figure 15. Others
Figure 16. Global Vasculitis Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 17. Global Vasculitis Drug Market Size (2018-2029) & (US$ Million)
Figure 18. Global Vasculitis Drug Sales (2018-2029) & (K Pcs)
Figure 19. Global Vasculitis Drug Average Price (USD/Pcs) & (2018-2029)
Figure 20. Vasculitis Drug Report Years Considered
Figure 21. Vasculitis Drug Sales Share by Manufacturers in 2022
Figure 22. Global Vasculitis Drug Revenue Share by Manufacturers in 2022
Figure 23. The Global 5 and 10 Largest Vasculitis Drug Players: Market Share by Revenue in 2022
Figure 24. Vasculitis Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 25. Global Vasculitis Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 26. North America Vasculitis Drug Sales Market Share by Country (2018-2029)
Figure 27. North America Vasculitis Drug Revenue Market Share by Country (2018-2029)
Figure 28. U.S. Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. Canada Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Europe Vasculitis Drug Sales Market Share by Country (2018-2029)
Figure 31. Europe Vasculitis Drug Revenue Market Share by Country (2018-2029)
Figure 32. Germany Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. France Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. U.K. Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Italy Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Russia Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Asia Pacific Vasculitis Drug Sales Market Share by Region (2018-2029)
Figure 38. Asia Pacific Vasculitis Drug Revenue Market Share by Region (2018-2029)
Figure 39. China Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Japan Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. South Korea Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. India Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Australia Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Taiwan Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Indonesia Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Thailand Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Malaysia Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Philippines Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Latin America Vasculitis Drug Sales Market Share by Country (2018-2029)
Figure 50. Latin America Vasculitis Drug Revenue Market Share by Country (2018-2029)
Figure 51. Mexico Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Brazil Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Argentina Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Middle East & Africa Vasculitis Drug Sales Market Share by Country (2018-2029)
Figure 55. Middle East & Africa Vasculitis Drug Revenue Market Share by Country (2018-2029)
Figure 56. Turkey Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 57. Saudi Arabia Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 58. UAE Vasculitis Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Global Sales Market Share of Vasculitis Drug by Type (2018-2029)
Figure 60. Global Revenue Market Share of Vasculitis Drug by Type (2018-2029)
Figure 61. Global Vasculitis Drug Price (USD/Pcs) by Type (2018-2029)
Figure 62. Global Sales Market Share of Vasculitis Drug by Application (2018-2029)
Figure 63. Global Revenue Market Share of Vasculitis Drug by Application (2018-2029)
Figure 64. Global Vasculitis Drug Price (USD/Pcs) by Application (2018-2029)
Figure 65. Vasculitis Drug Value Chain
Figure 66. Vasculitis Drug Production Process
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Distributors Profiles
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed